PMC:7127386 / 687-794 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"35","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"36","span":{"begin":13,"end":24},"obj":"Chemical"}],"attributes":[{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:D012254"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:C462182"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ribavirin or favipiravir that are currently evaluated under clinical trials showed no inhibition at 100 μM."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T8","span":{"begin":13,"end":24},"obj":"Chemical"}],"attributes":[{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"}],"text":"Ribavirin or favipiravir that are currently evaluated under clinical trials showed no inhibition at 100 μM."}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":0,"end":107},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ribavirin or favipiravir that are currently evaluated under clinical trials showed no inhibition at 100 μM."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T18","span":{"begin":0,"end":9},"obj":"CHEBI:85129;DG_29;CHEBI:85129"},{"id":"T19","span":{"begin":13,"end":24},"obj":"DG_17;NCBITaxon:31032"},{"id":"T26758","span":{"begin":0,"end":9},"obj":"CHEBI:85129;DG_29;CHEBI:85129"},{"id":"T58960","span":{"begin":13,"end":24},"obj":"DG_17;NCBITaxon:31032"},{"id":"T54781","span":{"begin":17,"end":25},"obj":"SO:0000704"},{"id":"T98320","span":{"begin":26,"end":34},"obj":"SO:0000853"},{"id":"T62840","span":{"begin":42,"end":50},"obj":"SP_10"},{"id":"T29138","span":{"begin":79,"end":82},"obj":"SP_2"},{"id":"T71046","span":{"begin":83,"end":96},"obj":"NCBITaxon:11118"}],"text":"Ribavirin or favipiravir that are currently evaluated under clinical trials showed no inhibition at 100 μM."}